China's National Medical Products Administration accepted Huadong Medicine's (SHE:000963) application for the registration of its Primelase Semiconductor Laser Therapy System, according to a Shenzhen bourse filing on Tuesday.
Primelase, which is developed by subsidiary High Technology Products, is a semiconductor laser multi-parameter adjustable therapeutic device,
The drugmaker's shares slipped 1% at the close.